| | | Single nucleotide variant (missense variant) | Gorlin syndrome +3 more | |
| | | Single nucleotide variant (missense variant) | Medulloblastoma +2 more | |
| | | Single nucleotide variant (synonymous variant) | Basal cell carcinoma, susceptibility to, 1 +3 more | |
| | | Single nucleotide variant (synonymous variant) | not provided +3 more | |
| | | Single nucleotide variant (missense variant) | Gorlin syndrome +2 more | |
| | | Single nucleotide variant (missense variant) | Basal cell carcinoma, susceptibility to, 1 +2 more | |
| | | Single nucleotide variant (missense variant) | not provided +3 more | |
| | | Single nucleotide variant (missense variant) | Gorlin syndrome +2 more | |
| | | Single nucleotide variant (missense variant) | Gorlin syndrome +2 more | |
| | | Single nucleotide variant (missense variant) | not specified +3 more | |
| | | Single nucleotide variant (missense variant) | Gorlin syndrome +2 more | |
| | | Single nucleotide variant (missense variant) | not provided +4 more | |
| | | Single nucleotide variant (missense variant) | Basal cell carcinoma, susceptibility to, 1 +2 more | |
| | | Single nucleotide variant (missense variant) | Capillary malformation-arteriovenous malformation syndrome +6 more | |
| | | Single nucleotide variant (synonymous variant) | Basal cell carcinoma, susceptibility to, 1 +5 more | |
| | CCNH, RASA1 (L205fs +1 more) | Deletion (frameshift variant +1 more) | Capillary malformation-arteriovenous malformation syndrome +3 more | |
| | CCNH, RASA1 (S219* +1 more) | Single nucleotide variant (nonsense +1 more) | Capillary malformation-arteriovenous malformation syndrome +2 more | |
| | | Single nucleotide variant (synonymous variant +1 more) | Capillary malformation-arteriovenous malformation syndrome +3 more | |
| | CCNH, RASA1 (R711* +1 more) | Single nucleotide variant (nonsense +1 more) | Capillary malformation-arteriovenous malformation syndrome +4 more | |
| | CCNH, RASA1 (R749* +1 more) | Single nucleotide variant (nonsense +1 more) | Capillary malformation-arteriovenous malformation syndrome +3 more | |
| | CCNH, RASA1 (I644K +1 more) | Single nucleotide variant (missense variant +1 more) | not provided +2 more | |
| | CCNH, RASA1 (Q1019* +1 more) | Single nucleotide variant (nonsense +1 more) | Capillary malformation-arteriovenous malformation syndrome +2 more | GPathogenic/Likely pathogenic |
| | | Single nucleotide variant (synonymous variant) | Hamartoma of hypothalamus +3 more | |
| | | Single nucleotide variant (missense variant +1 more) | Basal cell carcinoma, susceptibility to, 1 +3 more | |
| | | Single nucleotide variant (missense variant +1 more) | Basal cell carcinoma, susceptibility to, 1 +4 more | GConflicting classifications of pathogenicity |
| | | Single nucleotide variant (missense variant +1 more) | Basal cell carcinoma, susceptibility to, 1 +3 more | |
| | | Single nucleotide variant (missense variant +1 more) | Hereditary cancer-predisposing syndrome +4 more | GConflicting classifications of pathogenicity |
| | | Single nucleotide variant (missense variant +1 more) | Gorlin syndrome +4 more | GConflicting classifications of pathogenicity |
| | | Single nucleotide variant (missense variant +1 more) | Basal cell carcinoma, susceptibility to, 1 +3 more | |
| | | Single nucleotide variant (missense variant +1 more) | Gorlin syndrome +4 more | GConflicting classifications of pathogenicity |
| | | Single nucleotide variant (missense variant +1 more) | Hereditary cancer-predisposing syndrome +3 more | GConflicting classifications of pathogenicity |
| | | Single nucleotide variant (missense variant +1 more) | not provided +6 more | |
| | | Single nucleotide variant (missense variant +1 more) | Hereditary cancer-predisposing syndrome +3 more | GConflicting classifications of pathogenicity |
| | | Single nucleotide variant (missense variant +1 more) | Gorlin syndrome +4 more | GConflicting classifications of pathogenicity |
| | | Single nucleotide variant (missense variant +1 more) | Gorlin syndrome +4 more | |
| | | Single nucleotide variant (missense variant +1 more) | Hereditary cancer-predisposing syndrome +4 more | |
| | | Single nucleotide variant (missense variant +1 more) | Gorlin syndrome +5 more | GConflicting classifications of pathogenicity |
| | | Single nucleotide variant (missense variant +1 more) | PTCH1-related disorder +5 more | GConflicting classifications of pathogenicity |
| | | Single nucleotide variant (missense variant +1 more) | Hereditary cancer-predisposing syndrome +3 more | GConflicting classifications of pathogenicity |
| | | Single nucleotide variant (missense variant +1 more) | Gorlin syndrome +4 more | GConflicting classifications of pathogenicity |
| | | Single nucleotide variant (non-coding transcript variant +1 more) | Basal cell carcinoma, susceptibility to, 1 +2 more | |
| | | Single nucleotide variant (missense variant +1 more) | Hereditary cancer-predisposing syndrome +3 more | GConflicting classifications of pathogenicity |
| | | Single nucleotide variant (synonymous variant +1 more) | Holoprosencephaly 7 +5 more | |
| | | Single nucleotide variant (missense variant +1 more) | Gorlin syndrome +3 more | GConflicting classifications of pathogenicity |
| | | Single nucleotide variant (missense variant +1 more) | Basal cell carcinoma, susceptibility to, 1 +3 more | GConflicting classifications of pathogenicity |
| | | Single nucleotide variant (missense variant +1 more) | Basal cell carcinoma, susceptibility to, 1 +4 more | |
| | | Single nucleotide variant (missense variant +1 more) | Basal cell carcinoma, susceptibility to, 1 +5 more | GConflicting classifications of pathogenicity |
| | | Single nucleotide variant (missense variant +1 more) | Gorlin syndrome +4 more | GConflicting classifications of pathogenicity |
| | LOC100507346, PTCH1 (M833V +4 more) | Single nucleotide variant (non-coding transcript variant +1 more) | not provided +4 more | GConflicting classifications of pathogenicity |
| | LOC100507346, PTCH1 (N748H +4 more) | Single nucleotide variant (missense variant +1 more) | Hereditary cancer-predisposing syndrome +3 more | GConflicting classifications of pathogenicity |
| | LOC100507346, PTCH1 (I805V +4 more) | Single nucleotide variant (missense variant) | Hereditary cancer-predisposing syndrome +4 more | |
| | LOC100507346, PTCH1 (M737T +4 more) | Single nucleotide variant (missense variant) | Gorlin syndrome +3 more | |
| | LOC100507346, PTCH1 (V763F +4 more) | Single nucleotide variant (non-coding transcript variant +1 more) | Hereditary cancer-predisposing syndrome +4 more | GConflicting classifications of pathogenicity |
| | LOC100507346, PTCH1 (W664C +4 more) | Single nucleotide variant (non-coding transcript variant +1 more) | Hereditary cancer-predisposing syndrome +3 more | |
| | LOC100507346, PTCH1 (T728M +4 more) | Single nucleotide variant (non-coding transcript variant +1 more) | Basal cell carcinoma, susceptibility to, 1 +5 more | |
| | LOC100507346, PTCH1 (Q597H +4 more) | Single nucleotide variant (non-coding transcript variant +1 more) | not provided +4 more | GConflicting classifications of pathogenicity |
| | LOC100507346, PTCH1 (E538K +4 more) | Single nucleotide variant (non-coding transcript variant +1 more) | Hereditary cancer-predisposing syndrome +4 more | GConflicting classifications of pathogenicity |
| | | Single nucleotide variant (non-coding transcript variant +1 more) | Gorlin syndrome +3 more | |
| | | Single nucleotide variant (missense variant +1 more) | Hereditary cancer-predisposing syndrome +3 more | |
| | | Single nucleotide variant (missense variant +1 more) | Hereditary cancer-predisposing syndrome +4 more | GConflicting classifications of pathogenicity |
| | | Single nucleotide variant (missense variant +2 more) | Gorlin syndrome +3 more | GConflicting classifications of pathogenicity |
| | | Single nucleotide variant (missense variant +1 more) | Gorlin syndrome +3 more | |
| | | Single nucleotide variant (missense variant +1 more) | Gorlin syndrome +3 more | GConflicting classifications of pathogenicity |
| | | Single nucleotide variant (synonymous variant +1 more) | Holoprosencephaly 7 +5 more | |
| | | Single nucleotide variant (synonymous variant +1 more) | Holoprosencephaly 7 +5 more | |
| | | Single nucleotide variant (missense variant +1 more) | Gorlin syndrome +3 more | |
| | | Single nucleotide variant (missense variant +1 more) | Hereditary cancer-predisposing syndrome +4 more | GConflicting classifications of pathogenicity |
| | | Single nucleotide variant (missense variant +1 more) | Hereditary cancer-predisposing syndrome +3 more | GConflicting classifications of pathogenicity |
| | | Single nucleotide variant (intron variant) | Basal cell carcinoma, susceptibility to, 1 +3 more | |
| | | Single nucleotide variant (missense variant +2 more) | Hereditary cancer-predisposing syndrome +5 more | GConflicting classifications of pathogenicity |
| | | Single nucleotide variant (synonymous variant +2 more) | Basal cell carcinoma, susceptibility to, 1 +5 more | |
| | | Single nucleotide variant (missense variant +2 more) | Basal cell carcinoma, susceptibility to, 1 +4 more | GConflicting classifications of pathogenicity |
| | | Single nucleotide variant (missense variant +2 more) | not provided +4 more | GConflicting classifications of pathogenicity |
| | LOC130002133, PTCH1 (R13G) | Single nucleotide variant (missense variant +2 more) | Hereditary cancer-predisposing syndrome +5 more | GConflicting classifications of pathogenicity |
| | | Single nucleotide variant (5 prime UTR variant +1 more) | Gorlin syndrome +3 more | GConflicting classifications of pathogenicity |
| | | Single nucleotide variant (5 prime UTR variant +1 more) | Holoprosencephaly 7 +3 more | |
| | | Deletion (5 prime UTR variant +1 more) | Holoprosencephaly 7 +2 more | |